Search

everythinglearnresearchcommunity

for

Search:↓

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Birth control pills and cyproterone acetate can help treat acne in women, especially when linked to hormonal issues.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Medications for PCOS don't seem to raise heart disease risk.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Some supplements and hormones can increase hair loss by raising DHT levels.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

The Rotterdam Study aims to understand various diseases in older adults.

5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.

Lecithin organogels could be good for applying drugs to the skin because they are stable, safe, and can improve drug absorption.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

2% topical minoxidil effectively treats female hair loss with minimal side effects.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Jasmonic acid and its derivatives play important roles in plant health and have potential uses in medicine and agriculture.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.